HLVX
Price
$2.10
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
105.26M
61 days until earnings call
SLN
Price
$5.69
Change
+$0.46 (+8.80%)
Updated
Sep 5 closing price
Capitalization
226.72M
73 days until earnings call
Interact to see
Advertisement

HLVX vs SLN

Header iconHLVX vs SLN Comparison
Open Charts HLVX vs SLNBanner chart's image
HilleVax
Price$2.10
Change-$0.00 (-0.00%)
Volume$433.1K
Capitalization105.26M
Silence Therapeutics
Price$5.69
Change+$0.46 (+8.80%)
Volume$66.68K
Capitalization226.72M
HLVX vs SLN Comparison Chart in %
Loading...
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLVX vs. SLN commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLVX is a StrongBuy and SLN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (HLVX: $2.10 vs. SLN: $5.69)
Brand notoriety: HLVX and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HLVX: 68% vs. SLN: 94%
Market capitalization -- HLVX: $105.26M vs. SLN: $226.72M
HLVX [@Biotechnology] is valued at $105.26M. SLN’s [@Biotechnology] market capitalization is $226.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLVX’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • HLVX’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, HLVX is a better buy in the long-term than SLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLVX’s TA Score shows that 5 TA indicator(s) are bullish while SLN’s TA Score has 7 bullish TA indicator(s).

  • HLVX’s TA Score: 5 bullish, 2 bearish.
  • SLN’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, both HLVX and SLN are a good buy in the short-term.

Price Growth

HLVX (@Biotechnology) experienced а +0.48% price change this week, while SLN (@Biotechnology) price change was +18.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

HLVX is expected to report earnings on Nov 06, 2025.

SLN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLN($227M) has a higher market cap than HLVX($105M). HLVX YTD gains are higher at: 1.449 vs. SLN (-17.297). HLVX has higher annual earnings (EBITDA): -66.58M vs. SLN (-84.82M). HLVX has more cash in the bank: 160M vs. SLN (114M). SLN has less debt than HLVX: SLN (0) vs HLVX (23.5M). SLN has higher revenues than HLVX: SLN (27.2M) vs HLVX (0).
HLVXSLNHLVX / SLN
Capitalization105M227M46%
EBITDA-66.58M-84.82M78%
Gain YTD1.449-17.297-8%
P/E RatioN/AN/A-
Revenue027.2M-
Total Cash160M114M140%
Total Debt23.5M0-
TECHNICAL ANALYSIS
Technical Analysis
HLVXSLN
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 24 days ago
83%
Bullish Trend 1 day ago
88%
Declines
ODDS (%)
Bearish Trend 11 days ago
78%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOBQ1.540.04
+2.67%
Mobiquity Technologies, Inc.
NAUH0.05N/A
N/A
National American University Holdings, Inc.
CCOJF12.88N/A
N/A
Coca-Cola Bottlers Japan Inc.
NTOIF19.00N/A
N/A
Neste OYJ
YSASF0.85N/A
N/A
YESASIA HOLDINGS LTD.

HLVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLVX has been closely correlated with FBIOP. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if HLVX jumps, then FBIOP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLVX
1D Price
Change %
HLVX100%
N/A
FBIOP - HLVX
81%
Closely correlated
+4.69%
BRIBF - HLVX
58%
Loosely correlated
N/A
DNLI - HLVX
47%
Loosely correlated
+4.33%
NTLA - HLVX
45%
Loosely correlated
+3.79%
IPSC - HLVX
44%
Loosely correlated
+5.41%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
+8.80%
CLLS - SLN
43%
Loosely correlated
+1.90%
HLVX - SLN
35%
Loosely correlated
N/A
ANNX - SLN
35%
Loosely correlated
+0.93%
NGNE - SLN
33%
Loosely correlated
+1.73%
IDYA - SLN
32%
Poorly correlated
+5.15%
More